John C Jr. Burnett, MD

Professor

  • 35285 Citations
  • 94 h-Index
1975 …2020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 15 Similar Profiles
Heart Failure Medicine & Life Sciences
Atrial Natriuretic Factor Medicine & Life Sciences
Natriuretic Peptides Medicine & Life Sciences
Brain Natriuretic Peptide Medicine & Life Sciences
Kidney Medicine & Life Sciences
C-Type Natriuretic Peptide Medicine & Life Sciences
Endothelins Medicine & Life Sciences
Dogs Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1975 2020

INTRARENAL REGULATION OF SODIUM EXCRETION

Burnett, J. C. J., Costello, E. C. & Boerrigter, G.

National Institutes of Health

4/1/873/31/20

Project: Research project

Sodium
Heart Failure
Atrial Natriuretic Factor
Kidney
Natriuretic Peptides
National Heart, Lung, and Blood Institute (U.S.)
Research
Heart Failure
Research Personnel
Medicine
Metabolic Diseases
High-Throughput Screening Assays
Natriuretic Peptides
Cardiovascular Diseases
Brain Natriuretic Peptide

Research Output 1979 2019

High doses of ANP and BNP exacerbate lipolysis in humans and the lipolytic effect of BNP is associated with cardiac triglyceride content in pigs

Bartels, E. D., Guo, S., Kousholt, B. S., Larsen, J. R., Hasenkam, J. M., Burnett, J. C. J., Nielsen, L. B., Ashina, M. & Goetze, J. P., Feb 1 2019, In : Peptides. 112, p. 43-47 5 p.

Research output: Contribution to journalArticle

Lipolysis
Atrial Natriuretic Factor
Natriuretic Peptides
Nonesterified Fatty Acids
Triglycerides
1 Citations (Scopus)

A Human Study to Evaluate Safety, Tolerability, and Cyclic GMP Activating Properties of Cenderitide in Subjects With Stable Chronic Heart Failure

Kawakami, R., Lee, C. Y. W., Scott, C., Bailey, K. R., Schirger, J. A., Chen, H. H., Benike, S. L., Cannone, V., Martin, F. L., Sangaralingham, S. J., Ichiki, T. & Burnett, J. C. J., Jan 1 2018, (Accepted/In press) In : Clinical Pharmacology and Therapeutics.

Research output: Contribution to journalArticle

Cyclic GMP
Heart Failure
Safety
Natriuretic Peptides
C-Type Natriuretic Peptide
1 Citations (Scopus)

Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population

Cannone, V., Buglioni, A., Sangaralingham, S. J., Scott, C., Bailey, K. R., Rodeheffer, R., Redfield, M. M., Sarzani, R. & Burnett, J. C. J., Aug 1 2018, In : Mayo Clinic Proceedings. 93, 8, p. 980-990 11 p.

Research output: Contribution to journalArticle

Aldosterone
Antihypertensive Agents
Hypertension
Population
Atrial Natriuretic Factor

Bioactive Signaling in Next-Generation Pharmacotherapies for Heart Failure: A Review

Oatmen, K. E., Zile, M. R., Burnett, J. C. J. & Spinale, F. G., Jan 1 2018, (Accepted/In press) In : JAMA Cardiology.

Research output: Contribution to journalArticle

Heart Failure
Neprilysin
Angiotensin Receptors
Drug Therapy
Peptidyl-Dipeptidase A
1 Citations (Scopus)

CRRL269: a novel designer and renal-enhancing pGC-A peptide activator

Chen, Y., Harty, G. J., Huntley, B. K., Iyer, S. R., Heublein, D. M., Harders, G. E., Meems, L., Pan, S., Sangaralingham, S. J., Ichiki, T. & Burnett, J. C. J., Mar 1 2018, In : American journal of physiology. Regulatory, integrative and comparative physiology. 314, 3, p. R407-R414

Research output: Contribution to journalArticle

Kidney
Peptides
Canidae
Natriuretic Peptides
Renin-Angiotensin System